PLX vs MSFT: Which Stock is Better?
Side-by-side comparison of Protalix Biotherapeutics Inc and Microsoft Corporation in 2026
PLX
Protalix Biotherapeutics Inc
$2.64
MSFT
Microsoft Corporation
$498.41
Key Metrics Comparison
| Metric | PLX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $122.59M | $3.71T | MSFT |
| P/E Ratio | 30.80 | 33.89 | PLX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze PLX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PLX or MSFT a better investment?
Comparing PLX and MSFT: Protalix Biotherapeutics Inc has a market cap of $122.59M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PLX and MSFT?
PLX (Protalix Biotherapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PLX or MSFT?
Based on P/E ratios, PLX trades at a lower multiple (30.8x vs 33.9x).
Which is growing faster: PLX or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for PLX.
Which company is more profitable: PLX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for PLX.
Which is the larger company: PLX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $122.59M for PLX.
Should I buy PLX or MSFT in 2026?
Both PLX and MSFT have investment merit. PLX trades at $2.64 while MSFT trades at $498.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PLX and MSFT stock?
Key differences: Market Cap ($122.59M vs $3.71T), P/E Ratio (30.8x vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy PLX or MSFT in 2026?
The choice between PLX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PLX and MSFT?
PLX (Protalix Biotherapeutics Inc) has a market cap of $122.59M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.